
Sign up to save your podcasts
Or
Join Nicola Graham as she talks with Brett Drummond, the co-founder of MStranslate. Brett provides a summary of the highlights of ECTRIMs 2021, the largest global congress for MS researchers. Brett shares with us the most exciting and surprising MS research presented. Some topics covered include the latest on re-myelination therapies, COVID and vaccines for people living with MS, Gut Microbiome, Symptom Management and Stem Cell therapies.
With thanks to Brett.
Reach out for support:
MS Plus Connect 1800 042 138 or email [email protected]
Get in touch to share your comments and suggestions about this episode, or for future guests and episode topics by emailing [email protected]
Views expressed on the MS Podcast, including any discussions or reference to medications or treatments by podcast guests, do not necessarily represent the views of MS Plus and should not be seen as either an endorsement or rejection of a treatment.
MS Plus does not recommend any specific treatment for people living with MS. Decisions about any treatments, taking into consideration the potential benefits and side effects for each individual’s circumstances, should be made in careful consultation with the person’s neurologist or health care professional.
5
11 ratings
Join Nicola Graham as she talks with Brett Drummond, the co-founder of MStranslate. Brett provides a summary of the highlights of ECTRIMs 2021, the largest global congress for MS researchers. Brett shares with us the most exciting and surprising MS research presented. Some topics covered include the latest on re-myelination therapies, COVID and vaccines for people living with MS, Gut Microbiome, Symptom Management and Stem Cell therapies.
With thanks to Brett.
Reach out for support:
MS Plus Connect 1800 042 138 or email [email protected]
Get in touch to share your comments and suggestions about this episode, or for future guests and episode topics by emailing [email protected]
Views expressed on the MS Podcast, including any discussions or reference to medications or treatments by podcast guests, do not necessarily represent the views of MS Plus and should not be seen as either an endorsement or rejection of a treatment.
MS Plus does not recommend any specific treatment for people living with MS. Decisions about any treatments, taking into consideration the potential benefits and side effects for each individual’s circumstances, should be made in careful consultation with the person’s neurologist or health care professional.